Home Cart Sign in  
Chemical Structure| 23261-20-3 Chemical Structure| 23261-20-3

Structure of VAL-083
CAS No.: 23261-20-3

Chemical Structure| 23261-20-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

VAL-083 is a bi-functional alkylating agent and inhibits U251 and SF188 cell growth in monolayer better than TMZ and caused apoptosis.

Synonyms: Dianhydrodulcitol; Dianhydrogalactitol; Dulcitol Diepoxide

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of VAL-083

CAS No. :23261-20-3
Formula : C6H10O4
M.W : 146.14
SMILES Code : O[C@H]([C@H](O)[C@]1(OC1)[H])[C@@]2([H])CO2
Synonyms :
Dianhydrodulcitol; Dianhydrogalactitol; Dulcitol Diepoxide
MDL No. :MFCD01725532

Safety of VAL-083

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H315-H318-H335
Precautionary Statements:P280-P302+P352-P305+P351+P338+P310
Class:9
UN#:3077
Packing Group:

Related Pathways of VAL-083

DNA

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03149575 Glioblastoma Multiforme ... More >> Glioblastoma Glioma GBM Brain Cancer Less << Phase 3 Active, not recruiting August 2019 United States, California ... More >> Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States, 90027 University of California, San Francisco - Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey Atlantic Neuroscience Institute - Brain Tumor Center of NJ Summit, New Jersey, United States, 07901 United States, New York Dent Neurosciences Research Center Amherst, New York, United States, 14226 Less <<
NCT01478178 Glioma Gliobl... More >>astoma Glioblastoma Multiforme GBM Brain Cancer Less << Phase 1 Phase 2 Completed - United States, California ... More >> University of California, San Francisco, Division of Neuro-Oncology San Francisco, California, United States, 94143 United States, Colorado Sarah Cannon Research Institute Denver, Colorado, United States, 80218 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 Less <<
NCT03138629 - - - -
NCT03281681 Ovarian Cancer Phase 1 Phase 2 Not yet recruiting June 2020 United States, Arizona ... More >> St. Joseph's Hospital and Medical Center Not yet recruiting Phoenix, Arizona, United States, 85013 Contact: Bradley J Monk, M.D.    602-406-7730    bradley.monk@chw.edu    United States, Michigan Henry Ford Hospital Not yet recruiting Detroit, Michigan, United States, 48202 Contact: Ding Wang, M.D., Ph.D.    800-436-7936       United States, Tennessee Sarah Cannon Research Institute Not yet recruiting Nashville, Tennessee, United States, 37203 Contact: Howard A Burris, M.D.    615-320-5090 Less <<
NCT02717962 Glioma Gliobl... More >>astoma Glioblastoma Multiforme GBM Brain Cancer Less << Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Kathy Hunter, R.N.    713-745-5769    kuhunter@mdanderson.org    Contact: Stephanie Knight, B.S.N., R.N.    713-563-8746    SRKnight@mdanderson.org    Principal Investigator: Barbara O'Brien, M.D.          Sub-Investigator: Marta Penas-Prado, M.D.          Sub-Investigator: Rivkah Cohen, M.D.          Sub-Investigator: Carlos Kamiya-Matsuoka, M.D.          Sub-Investigator: John DeGroot, M.D.          Sub-Investigator: Monica Loghin, M.D.          Sub-Investigator: Shiao-Pei Weathers, M.D.          Sub-Investigator: W.K. Alfred Yung, M.D.          Sub-Investigator: Greg Fuller, M.D.          Sub-Investigator: Kenneth Hess, Ph.D. Less <<
NCT03050736 Glioma Gliobl... More >>astoma Glioblastoma Multiforme GBM Brain Cancer Less << Phase 2 Recruiting August 2019 China ... More >> Sun Yat-Sen University Cancer Center Recruiting Guangzhou, China, 510060 Contact: Chen Zhong-ping, M.D., Ph.D.    +86 (20) 87343310    chenzhp@sysucc.org.cn Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

6.84mL

1.37mL

0.68mL

34.21mL

6.84mL

3.42mL

68.43mL

13.69mL

6.84mL

References

 

Historical Records

Categories